Rate My Professor Philip Hill

Professor Hill's research specializations encompass studies of Mycobacterium tuberculosis infection and disease, Streptococcus pneumoniae carriage, disease, and vaccination, within broader international health initiatives including tuberculosis and pneumonia projects across Africa, Asia, Europe, South America, and the Pacific. He maintains major collaborations, such as with the TB-HIV research centre at the University of Padjadjaran in Bandung, Indonesia, transitioning from observational studies to intervention trials, and serves as Adjunct Professor at the Communicable Diseases Research Centre of Fiji National University, dedicating 20% of his time to capacity building. He has supervised over 30 masters and PhD students from low-resource settings, achieving high completion and publication rates. As lead or co-investigator, he has obtained grants from the Bill & Melinda Gates Foundation, UK Medical Research Council, European Commission, DFID, Canadian Institutes of Health Research, New Zealand Health Research Council, Marsden Fund, and others. Key publications include 'Global biological sample collections from tuberculosis studies: A scoping review' (2026, Lancet Microbe), 'The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale' (2025, Lancet Microbe), and 'Resurgence of rheumatic fever among Pacific peoples in Aotearoa New Zealand: A 2010-2023 analysis of hospitalisation data with implications for equity policy' (2025, Australian & New Zealand Journal of Public Health). He has authored approximately 250 peer-reviewed articles, contributing significantly to global infectious disease research and training.